We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
In This Issue of JAMA Ophthalmology |

Highlights FREE

JAMA Ophthalmol. 2014;132(9):1041. doi:10.1001/jamaophthalmol.2013.5958.
Text Size: A A A
Published online


There is minimal information on the subsequent effect of telemedicine activities on eye care resources. Chasan and colleagues retrospectively evaluate the effect of a community-based diabetic telemedicine retinal screening program on eye care use. Common referral diagnoses were nonmacular diabetic retinopathy (43.2%), nerve-related disease (30.8%), lens or media opacity (19.1%), age-related macular degeneration (12.9%), and diabetic macular edema (5.6%). The percentage of agreement among these was 90.4%, with a total sensitivity of 73.6%. Using Medicare cost data estimates, the mean cost incurred in 2 years per patient seen in the eye clinic was about $1000.

While hydroxychloroquine sulfate retinopathy can progress after the drug is stopped, it is not clear how this relates to the stage of retinopathy or whether identification at an early stage of the retinopathy with modern imaging technology can prevent progression and visual loss. Marmor and Hu determine the relationship between worsening of retinopathy and severity of disease using objective data from optical coherence tomography (OCT) in patients with hydroxychloroquine retinopathy monitored with repeated anatomical and functional examinations for 13 to 40 months after the drug was stopped. Patients with hydroxychloroquine retinopathy involving the retinal pigment epithelium demonstrated progressive damage on OCT for at least 3 years after the drug was discontinued. Study findings suggest that early recognition of hydroxychloroquine toxic effects before any fundus abnormalities are visible should minimize late worsening and the risk of visual loss.

Understanding relationships between measurements obtained on different optical coherence tomography (OCT) machines is critical. Investigators from the Diabetic Retinopathy Clinical Research Network evaluate the reproducibility of retinal thickness measurements from OCT images obtained by time-domain (TD) (Stratus) and spectral-domain (SD) (Cirrus and Spectralis) instruments and formulate equations to convert retinal thickness measurements from this SD-OCT to equivalent values on TD-OCT in eyes with diabetic macular edema. The Bland-Altman coefficient of repeatability for relative change in central subfield thickness (CST) was lower with Spectralis (7%) compared with Cirrus (14%) and Stratus (12% and 15% within Cirrus/Stratus and Spectralis/Stratus groups, respectively). The conversion equations predicted a Stratus CST within 10% of the observed thickness 86% and 89% of the time for Cirrus/Stratus and Spectralis/Stratus groups, respectively.

Approximately 5% to 10% of patients continue to experience persistent epiphora following an anatomically successful dacryocystorhinostomy (DCR) for nasolacrimal duct obstruction or stenosis. Shams and colleagues investigate the management and success rate of so-called “functional failure” of DCR for nasolacrimal duct obstruction by experienced lacrimal surgeons. Among 61 patients with functional epiphora after 65 DCRs, epiphora recurred a mean of 8.9 months after primary DCR. Intubation with a lacrimal stent was performed in 82% of the cases, and all stents were removed a mean of 8 weeks postoperatively. Among 39 interventions of intubation with a silicone stent, 54% were successful and almost half undergoing intubation elected to keep the stent permanently. Twenty-two had an eyelid-tightening procedure, with success in 50%. The authors concluded that while functional epiphora after DCR among patients with preoperative nasolacrimal duct obstruction or stenosis appears to be uncommon, additional intervention can result in subsequent benefits in most patients with intubation or eyelid tightening.





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.